The Czech startup has obtained MDR certification and is now expanding internationally. JIC Ventures is participating in its pre-seed round – marking the CEE fund’s third deal.
BRNO, CZECH REPUBLIC, July 14, 2026 /EINPresswire.com/ — JIC Ventures has entered the pre-seed round of HTG Medical, a Czech medtech firm that automates urine output tracking in intensive-care settings. Garage Angels and Electron Capital Partners led the round, with returning backers Jinej fond and Dendis Capital also contributing. The €450,000 investment arrives as the company secures European Medical Device Regulation certification and gears up for entry into foreign markets.
Based in Prague, the startup has created the HTG Urogram, one of only a handful of devices worldwide that fully replaces manual urine output charting with automated monitoring, transmitting data directly into the hospital information system. In intensive-care units, this saves nurses up to an hour of daily work and reduces mistakes. The product has been validated through live use on the cardiovascular ICU at Prague’s IKEM.
For JIC Ventures, HTG Medical represents precisely the type of company the fund targets – and in a sector where many funds hesitate to invest.
“HTG Medical came about the way technology startups are meant to – out of a real problem named by the people on the ground. The doctors at IKEM knew what wasn’t working, and the team turned that into a product. Not every fund has the appetite or the backing to invest in hardware and software; for us it’s natural territory. That’s part of why HTG Medical is now in our portfolio,” says Radim Kocourek, Managing Partner of JIC Ventures.
Miloš Sochor, Managing Partner of JIC Ventures, highlights the commercial reasoning behind the product: “They come with a model where the customer doesn’t spend more than they do today but gets automation and data on top. In hospitals, that’s a real way in. The team is fast, motivated, and now holds a certification that opens the door to its first sales. The ambition to move into Europe is, in this case, a logical next step, not just an aspiration.”
Returning investors, a signal to new ones
Garage Angels, a Brno Region angel syndicate, led the pre-seed round alongside Electron Capital Partners.
“Healthcare is a segment where innovation takes hold slowly and with difficulty, which made us even more convinced by the HTG Medical team, who took Urogram from a hackathon idea to a certified product deployed with real patients. The combination of a strong founding team, MDR certification and a clear business model with recurring revenue was decisive for us. We believe HTG has the potential to become a commercially successful medtech solution on global markets, and we’re glad to be part of it,” says Aleš Filipenský, investment director at Garage Angels.
In this round, JIC Ventures was joined by Jinej fond and Dendis Capital, both of which had previously invested in HTG Medical.
“Total offers in this round exceeded €1 million, more than double the planned amount. In the end we decided to accept only part of the capital on offer, but that interest confirms that investors believe in the direction HTG Medical is taking,” comments Max Klimeš, CTO and co-founder of HTG Medical.
Certification as a springboard abroad
Altogether, the company has now raised over €1 million at the pre-seed stage. The new €450,000 infusion will be directed toward international expansion and market entry.
Europe’s Medical Device Regulation (MDR), tightened in recent years, is among the most rigorous globally. HTG Urogram – backed by more than 4,000 hours of bedside testing and successful pilot deployments in several Czech hospitals, including IKEM – completed the full certification process in 15 months. This certification also unlocks opportunities beyond Europe, acting as a regulatory stepping stone for expedited registration in other markets, such as Australia, Singapore, Malaysia, and Saudi Arabia.
The immediate focus, however, is on Europe: the company has already established partnerships with international distributors and is preparing to enter Austria, Spain, France, and the Netherlands. HTG Medical’s ambitions extend beyond automated urine output monitoring – additional devices are in development that integrate into hospital infrastructure, shifting the company from a single measuring instrument toward a comprehensive platform for ICU automation.
Support from JIC Ventures may accelerate that journey. Alongside capital, the fund provides access to a network of seasoned founders, mentors, and ecosystem partners built over the past two decades around the JIC innovation agency. The investment in HTG Medical is the new fund’s third, following its launch in April 2026.
Jana Pokorná
JIC
email us here
Visit us on social media:
LinkedIn
